Kiely John
- SEC CIK
- 0001781149
In the past year, 1 open-market sale filing worth $882.0K and no purchases.
Current role at each company
- AMRX Amneal Pharmaceuticals, Inc.Directoras of Aug 14, 2026
- ZVO Zovio IncDirectoras of Sep 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $882.0K
- 1 filing
- Net
- −$882.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kiely John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMRX Amneal Pharmaceuticals, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 (view filing)4:29 PM ET | Aug 13 | 1 day | Kiely JohnDirector | SSaleClass A Common Stock | −50.0K | $17.64 | −$882.0K | −19.2%210.3K after | |
| Aug 28, 2025 (view filing) | Aug 27 | 1 day | Kiely JohnDirector | SSaleClass A Common Stock | −32.0K | $9.23 | −$295.4K | −12.4%225.4K after | |
| May 13, 2025 (view filing) | May 12 | 1 day | Kiely JohnDirector | SSaleClass A Common Stock | −50.0K | $7.59 | −$379.5K | −16.3%257.4K after | |
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Kiely JohnDirector | SSaleClass A Common Stock | −17.1K | $8.38 | −$142.9K | −6.0%267.2K after |